Salmon Sean 4
4 · Medtronic plc · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Salmon Sean
EVP & Group President Diabetes
Transactions
- Sale
Ordinary Shares
2024-02-21$85.06/sh−1,594$135,586→ 77,390 total - Sale
Ordinary Shares
2024-02-21$85.15/sh−13,066$1,112,570→ 64,324 total - Sale
Ordinary Shares
2024-02-21$85.12/sh−16,035$1,364,899→ 48,289 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-21−1,594→ 13,066 totalExercise: $62.76From: 2015-07-28Exp: 2024-07-28→ Ordinary Shares (1,594 underlying) - Exercise/Conversion
Ordinary Shares
2024-02-21$62.76/sh+13,066$820,022→ 62,949 total - Exercise/Conversion
Ordinary Shares
2024-02-21$62.76/sh+1,594$100,039→ 49,833 total - Exercise/Conversion
Ordinary Shares
2024-02-21$74.84/sh+16,035$1,200,059→ 78,984 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-21−16,035→ 0 totalExercise: $74.84From: 2016-01-27Exp: 2025-01-27→ Ordinary Shares (16,035 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-21−13,066→ 0 totalExercise: $62.76From: 2015-07-28Exp: 2024-07-28→ Ordinary Shares (13,066 underlying)
Footnotes (3)
- [F1]Includes 186 units acquired through dividend reinvestment since the last report filed by the reporting person.
- [F2]The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.
- [F3]The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.